EDGAR Filing Documents for 0001493152-15-000434

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-15-000434

Filing Date

2015-02-10

Accepted

2015-02-10 16:15:03

Documents

Period of Report

2014-03-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	584491
2		ex31-1.htm	EX-31.1	16500
3		ex31-2.htm	EX-31.2	16730
4		ex32-1.htm	EX-32.1	5959
5		ex32-2.htm	EX-32.2	6093
	Complete submission text file	0001493152-15-000434.txt		6151016

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE FILE	corx-20140331.xml	EX-101.INS	735533
7	XBRL SCHEMA FILE	corx-20140331.xsd	EX-101.SCH	76174
8	XBRL CALCULATION FILE	corx-20140331_cal.xml	EX-101.CAL	37479
9	XBRL DEFINITION FILE	corx-20140331_def.xml	EX-101.DEF	278642
10	XBRL LABEL FILE	corx-20140331_lab.xml	EX-101.LAB	500158
11	XBRL PRESENTATION FILE	corx-20140331_pre.xml	EX-101.PRE	331662

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452

Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)